Conmed Corp

Research Conmed Corp (CNMD) on Bullrun: valuation model: 20.0% undervalued, market cap USD 1.04B, P/E 19.4, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCNMD
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Valuation signal20.0% undervalued
• Market capUSD 1.04B
• P/E19.4
• Dividend yield0.6%
• Financial periodFY2025
• RevenueUSD 1.37B
• Revenue growth5.2%
• Net incomeUSD 47.10M
• Free cash flowUSD 150.88M
• Gross margin54.6%

Valuation Snapshot

Bullrun's latest valuation model marks Conmed Corp as 20.0% undervalued; latest market cap is USD 1.04B; P/E is 19.4; dividend yield is 0.6%.

About Conmed Corp

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.

Frequently asked questions

Is Conmed Corp overvalued or undervalued?

Bullrun's valuation model currently marks Conmed Corp as 20.0% undervalued.

What is Conmed Corp's market cap?

Conmed Corp's market capitalization is USD 1.04B.

What is Conmed Corp's P/E ratio?

Conmed Corp's price-to-earnings (P/E) ratio is 19.4.

Does Conmed Corp pay a dividend?

Conmed Corp has a dividend yield of 0.6%.

What does Conmed Corp do?

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.